Part: 12         Session: 145678910111213141516171819202122         Page 793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860 of 999

something, and we have indeed told them things.

If Hoffmann-LaRoche is the leader and stays the leader, it's due to our visit of June 15th, 1978, because they had no idea of the clinical results at M. D. Anderson, or where to get the blood, they had no idea there was anybody willing to buy it. Our visit, and Dr. Gutterman's clinical results and his offer to supply them with white cells in large amounts, changed their whole picture, and they are far, far along at the present moment.

Now you don't know what somebody will do in left field. You don't know. Maybe somebody will find something cheaper and easier to make like chopped grass or something crazy, but as of the moment it's a horse race as to who is going to get this vast market for viral disease and cancer. I mean it will be a group -- it may be a three or four group of people -- but sometimes in the case of the antibiotics the people who started the antibiotics weren't the people that got the business.

Exactly, no.

But the people that got the business would never have been in there if it hadn't been for the people that started, because they got the idea from them, and they found how to do it differently or better.

I have an article for you from Business Week which came in November of last year, and I thougth it was a very good